All articles tagged with #oxford nanopore
The NHS is piloting a rapid genomic test that reduces brain tumour diagnosis times from up to eight weeks to two hours, allowing surgeons to make decisions during operations. Developed by the University of Nottingham, the test uses Oxford Nanopore technology to analyze DNA samples in a shoebox-sized machine. It is currently being tested in five specialist centres across England, with plans for wider rollout.
The NHS has launched a two-year pilot for a rapid genomic test that classifies brain tumours in two hours, reducing the standard diagnostic wait from up to eight weeks. Developed by the University of Nottingham, the technology uses Oxford Nanopore sequencing to provide surgeons with critical genetic data during operations, potentially accelerating treatment and clinical trial access for the 12,000 UK patients diagnosed annually.
A new genomic test is cutting brain tumour diagnosis times from up to eight weeks to two hours. The NHS is piloting the technology at five specialist centres in England, allowing surgeons to make critical decisions during operations. Developed by the University of Nottingham, the test uses Oxford Nanopore sequencing to analyse tumour DNA rapidly, potentially accelerating treatment and clinical trial access for the 12,000 UK patients diagnosed annually.